Craig A. Collard - 13 May 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role
Director
Signature
/s/ Craig Collard
Issuer symbol
N/A
Transactions as of
13 May 2022
Net transactions value
+$38,698
Form type
4
Filing time
16 May 2022, 16:05:15 UTC
Previous filing
10 Jan 2022
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OPNT Common Stock Purchase $38,698 +3,689 +21% $10.49 20,972 13 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $10.47 to $10.50. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.